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Abstract The current challenge to ecotoxicology is to
develop tools that allow rapid and cost-efficient detection
of those environmental chemicals or their combinations
that are responsible for sublethal, chronic toxic effects in
exposed organisms. Bioanalytical tools may meet these
challenges, particularly if they are mechanism-based.
Technically, bioanalytical tools allow rapid and cost-effi-
cient analysis of environmental matrices. Mechanism-
based, bioanalytical tools, however, do not only indicate
that certain chemicals are there, but – and this is the ma-
jor advantage of mechanism-based bioanalytical tools
(MBBTs) – they indicate that chemicals with a specific
mode of toxic action or a specific toxic potential are there.
In this way MBBTs bridge exposure and effect assessment
and help in a faster identification of the causative
agent(s). Several principles of MBBTs, including im-
munoassays, enzyme inhibition assays, receptor assays
and gene induction assays are briefly discussed and their
application in processes such as bioassay-directed frac-
tionation is illustrated. The focus of this manuscript is the
analytical power of MBBTs in exposure and effect assess-
ment. MBBTs have, however, a much broader potential
and can support research on other challenges in ecotoxi-
cology such as mixture effects or multiple effects caused
by single pollutants or by various stresses simultaneously.
Keywords Bioassay · Biomarker · Immunoassay · 
Nuclear receptor · Reporter gene · Biosensor
Abbreviations MBBT mechanism-based bioanalytical
tool · RIA radioimmunoassay · ER estrogen receptor ·
RRA radioreceptor assay · ELRA enzyme-linked receptor
assay · TIE toxicity identification evaluation
Introduction
Ecotoxicology is the scientific discipline that is concerned
with the impact of pollutants on biota in ecosystems. The
technological goal of ecotoxicology is to develop and ap-
ply tools for assessing contaminant fate and effects in the
biosphere [1]. Central to the achievement of this goal is
the availability of exposure and effect assessment tools
capable of dealing with the actual and future difficulties in
ecotoxicology. Currently, environmental exposure assess-
ment is done mainly by analytical chemistry, aimed at mea-
suring known pollutants in environmental matrices. Effect
assessment relies largely on laboratory toxicity tests mea-
suring the effects of single substances or environmental
samples on death, growth and (partly) reproduction of sin-
gle, selected test species.
The ecotoxicological methodology was developed largely
during the 1970s and 1980s when environmental systems
were challenged by high concentrations of toxicants, and
public awareness of environmental pollution was domi-
nated by catastrophic events such as oil spills and overt
effects such as mass mortalities. The focus of exposure as-
sessment was on single “priority” pollutants which were
selected a priori on the basis of laboratory-derived toxico-
logical data or their production volumes. The focus of ef-
fect assessment was on acute exposure to high concentra-
tions, and therefore, relatively crude endpoints such as
death or retarded growth were sufficient.
The levels of many contaminants in the environment
decreased during the last few decades, and acutely lethal
effects are no longer the predominant problem in ecotoxi-
cology. Hence, the ecotoxicological tools that were devel-
oped in the past, based on problems in the past, are be-
coming under pressure, and there is a need to develop ap-
proaches and tools that are able to address the actual chal-
lenges in environmental contamination. Current difficul-
ties in assessing environmental contamination include [2]:
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i) low doses of contaminants, often with chronic exposure,
ii) multiple effects of one and the same compound, iii) mix-
tures of a wide variety of compounds, including not only in-
dustrial chemicals but household chemicals, pharmaceutical
compounds or substances arising from lifestyle changes (e.g.
musk compounds). This situation leads to new challenges in
both exposure and effect assessment. The chemical analyti-
cal approach focusing on single, selected toxicants as is still
predominantly the case today, is limited in the evaluation of
these complex mixtures of known and unknown substances
and their metabolites, as being present at mostly low con-
centrations in surface waters and effluents. Exposure as-
sessment by chemical analysis requires an a priori selection
of the compounds to be analysed and thereby may miss toxi-
cologically important substances. In effect assessment, a ma-
jor problem is that currently available ecotoxicity data are
mainly acute lethality data, which provide no information
on the possible chronic and sublethal effects of low-dose,
long-term exposures. Furthermore, when comparing con-
centrations of individual, analytically determined toxicants
with effect thresholds, the effects of non-analysed toxicants
or their metabolites, or for the combinatory effect of mix-
tures is not accounted for. In this situation, an approach that
analyses the presence of environmental contaminants with
respect to the biological effects occurring at these concen-
trations would allow one to assess the actual hazard of the
biologically active constituents in the complex mixture. In
order to go beyond just analytical detection and to bridge
exposure and effect assessment, such a bioanalytical ap-
proach has to be mechanism-based. Organisms respond to
toxicant stress by a variety of molecular and cellular re-
sponses with some of these mechanisms being specific for
certain chemical classes or structures, and at the same time
being indicative of a specific mode of toxic action [3].
Mechanism-based bioanalytical tools offer several advan-
tages, for instance, they support the systematisation and in-
terspecies extrapolation of chemical effects. This would al-
low one to address the issue of mixture toxicity, low-dose
effects and would help in acquiring generalizable princi-
ples. A further advantage of mechanism-based bioanalytical
tools is that the biological targets used and validated in the
development of these tools could also be utilized for in situ
effect assessment on wildlife species. At its best, a bioana-
lytical method will integrate analytical with toxicological
information.
For the purpose of this review, we define mechanism-
based bioanalytical tools (MBBTs) as methods that utilize
quantifiable and specified detection principles. In this de-
finition, emphasis is on the analytical aspect; the principle
for analysis is not a physical one as in chemical analytics,
but the detection is based on a defined chemical–biologi-
cal interaction. Such a definition excludes integrative re-
sponse parameters (e.g. cytotoxicity), which do not allow
the detection of a specific interaction between the analyte
and the biological element. Despite the fact that immuno-
assays do not represent a mode of toxic action and thus
are not considered a MBBT, we include immunoassays in
this review because they do utilize specific chemical-bio-
logical interactions as their analytical principle.
An example illustrating the potential deficits in current
exposure and effect assessment is provided by the evalua-
tion of endocrine disruptors. Existing, rather crude eco-
toxicological tests procedures do not address this form of
toxic impact of environmental substances on biota, and
accordingly, environmental substances with endocrine ac-
tivity have not been included in chemical analytical mon-
itoring programmes until recently. In addition, some of
these endocrine-active compounds can induce significant
biological effects such as disturbed reproduction at con-
centrations that are close to current detection limits of
chemical analytical techniques. A further complication of
exposure and effect assessment of endocrine disruptors
comes from the still preliminary observations that mix-
tures of endocrine-active substances can act additively, an
effect that can be not predicted from chemical analytics.
This phenomenon of concentration additivity has also been
shown to occur with other pharmaceutical compounds,
stressing the relevance of this issue [4]. Since many of the
hormonally active environmental compounds exert their
biological activity through interaction with endogenous
hormone receptors, bioanalytical approaches can take ad-
vantage of this mechanism and can instrumentalize recep-
tor binding as a means to detect the overall endocrine po-
tency of an environmental sample as it arises from the
combined action of all receptor-binding chemicals being
present in the sample. The need to develop bioanalytical
tools on the basis of sound mechanistic knowledge can
also be illustrated with recent developments described in
the literature. The identification of more than one estro-
gen receptor, each having different expression profiles in
various tissues, as well as the presence of non-receptor-
mediated signalling pathways clearly show that before de-
veloping and using bioanalytical tools it is important to
know the underlying mechanisms and the relevant targets
in order to be able to understand the biological meaning of
the toxicant-induced responses [5].
Interest in novel ecotoxicological methodology arises
not only from the limitations of the current exposure and
effect assessment tools but also from the need to improve
the efficiency, both in terms of cost efficiency and through-
put efficiency [6]. Chemical analysis of environmental me-
dia for possible hazardous compounds can be exorbitantly
expensive and time consuming. Thus, cost-effective and
high-throughput methods are required to solve the problem
of analysing large numbers of environmental samples [7,
8]. Many bioanalytical methods are microscale assays
which is an advantage for high-throughput testing. Further,
bioanalytical techniques could reduce costs of conven-
tional analytical chemistry in that they could identify those
samples which are positive for certain types of toxic chem-
icals, they can sort out negative samples, and can direct
chemical analysis to the search for the causative chemicals.
Principles of bioanalytical tools
The development of bioanalytical tools requires sound mech-
anistic knowledge of the mode of action of contaminants.
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First interactions of pollutants occur at the cellular level.
Upon interactions of pollutants in the cell, proteins can be
modified, membrane functions get altered or genes get ac-
tivated in a fine-tuned and coordinated way aimed at main-
taining the cellular homeostasis. Both general stress re-
sponses and stress-specific responses may occur simulta-
neously. Detailed examination of the molecular, biochem-
ical, cellular reactions should be made before the relevant
and stress-specific molecular processes, key regulatory
components and target genes can be identified. This ap-
proach and the resulting mechanistic knowledge allow
one to study the complex chronic effects, mixture effects
and multiple effects. This knowledge also allows one to
assess toxic effects at an early stage, even before effects
can be seen in whole organisms, and can be used to de-
velop stress-specific and powerful MBBTs.
When trying to categorize the various bioanalytical
methods, we have to distinguish between the primary inter-
action of the chemical with a biological target molecule or
target mechanism which forms the basis of the method, and
the subsequent transformation of the primary interaction
into a quantifiable signal. For instance, the primary chemi-
cal–biological interaction may consist of the binding of the
chemical as ligand to a biological receptor, and this ligand–
receptor interaction may subsequently be quantified as lu-
ciferase gene expression in a cell reporter gene bioassay.
In the following discussion, we will present several
principles of bioanalytical methods. The intention is not to
provide a comprehensive overview of the existing litera-
ture or assays, but to exemplify principles and methods
and to use these examples to discuss promises and limita-
tions of the assays, particularly with respect to the poten-
tial bridging function of MBBTs between exposure and
effects assessment.
Immunoassays
This type of bioanalytical method is not mechanism-based,
but takes advantage of the biological ability of antibodies
to bind selectively and specifically molecular structures.
Thus, immunoassays analyse the presence of specific
chemicals but they do not provide information on the bio-
logical target of the analytes. Compared to the conven-
tional methods of chemical analytics, the main difference
of immunoassays is that they do not use a physical or
physicochemical principle for the detection of the analyte,
but they rely on antibodies as the detection principle and
exploit the ability of these molecules to selectively recog-
nize structural properties of organic molecules. Most im-
munoassays use monoclonal antibodies produced by hy-
bridoma cells. If antibodies are to be generated against
small analytes, it may be necessary to conjugate them to a
larger carrier molecule such as bovine serum albumin to
render them immunogenic. The site of conjugation and
the linkage can influence the specificity and selectivity of
the antibody generated.
In immunoassays, the binding event is usually visual-
ized by an auxiliary reaction, in which an immunoreactant
or analyte is labelled with an easy measurable substance
(e.g. spectrophotometric methods). For immunochemical
detection of environmental contaminants, either competi-
tive or non-competitive assays may be used. In the non-
competitive assays, the antibody binds the antigen/ana-
lyte, and the resulting antibody–antigen complex is visu-
alized by binding of a second, labelled antibody. The la-
belling signal produced is directly proportional to the
amount of bound analyte. In the competitive immunoas-
say, the labelled analyte competes with the possible nat-
ural analyte for the binding site of the antibody [6, 9, 10,
11]. The first step of the assay is that the well of a mi-
croplate is coated with the antibody. The sample matrix
containing the analyte is then added to the well, and the
immobilized antibody binds the analyte. After washing,
the antibody is incubated with labelled analyte which binds
to the free antibody binding sites. After rinsing, the amount
of labelled and bound analyte is quantified. The amount
of analyte in the unknown sample is interpolated from a
calibration curve. It is inversely proportional to the amount
of labelled analyte. Alternative competitive immunoassay
protocols to the one described here have been developed,
for instance the use of magnetic particles to separate bound
and unbound analyte; however, the principle of the assay
remains the same [12].
Various labels can be used to quantify the amount of
bound tracer molecule. Many immunoassays use radioac-
tive labels (radioimmunoassays, RIA). These techniques,
however, suffers from several shortcomings, including the
safety problems inherent with the use of radioactive mate-
rials, the cost of instrumentation and the limited half-life
of radioisotopes. An alternative labelling technique is the
use of enzyme tracers to provide the quantification signal.
In this case, an enzyme such as horseradish peroxidase or
alkaline phosphatase is conjugated to the tracer molecule,
and this enzyme converts a colourless substrate into a
coloured or a light-emitting product. The amount of colour
or light produced is proportional to the amount of bound
tracer molecule. The use of chemiluminescent or fluores-
cent instead of colorimetric labels can increase the sensi-
tivity of the assays [13]. The advantages of enzyme im-
munoassays for environmental analytics are the long shelf
lives, ease of distribution and suitability for field use [6,
14].
Immunosensors provide an alternative to enzyme-de-
pendent detection systems and rely on electrochemical de-
tection principles. Such immunosensors can be used to
quantify the antibody–antigen interaction [10, 11, 15, 16].
Electrochemical immunoassays either indicate the anti-
body–antigen binding directly by measuring changes in
charge densities or conductivities of an immobilized anti-
body layer, or they utilize amperometric or other transduc-
ers to quantify the antibody–antigen reaction indirectly [11].
An important advantage of the electrochemical methods is
the possibility to develop hand-held devices for on-site
measurements.
Immunoassay techniques for environmental contami-
nants were introduced in the early 1970s [17] and assays
for a range of xenobiotics have been developed since, in-
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cluding PCBs [18], pesticides [19], herbicides [20], heavy
metals [21], surfactants [22] and environmental estrogens
[23]. A number of methods have been established for diox-
ins and related compounds, since routine monitoring of
these compounds is difficult, time consuming and expen-
sive; thus, screening methods that offer improvements in
speed, sample throughput and cost are particularly desir-
able. Therefore, the early immunoassays for environmen-
tal contaminants include several dioxin assays [24]. Harri-
son et al. [25] developed immunoassays against dioxin and
related compounds which are now commercially available
and which are based on the DD3 monoclonal antibody.
These assays have a sensitivity reaching the picogram
level and were found to show a response roughly propor-
tional to the toxic potency of the analysed congeners [9,
26]. Dioxin and PCB immunoassays have been success-
fully applied to the analysis of soil, water, fly ash and bi-
ological tissue extracts, although examination of the last
of these usually requires rather extensive sample prepara-
tion [26, 27, 28]. The correlation between dioxin equiva-
lents derived from chemical analytical measurements or
derived from immunoassays were found to be reasonably
good. For instance, in a screening study on the dioxins
and furans in fly ash from a municipal waste incinerator,
Focant et al. reported r2-values of 0.84 for the correlation
between MS/MS analytical data and immunoassay data
[29]. For PCB levels in fish extracts, Zajicek et al. found
an r2-value of 0.75 [28]. A good correlation (r2 = 0.92) be-
tween chemical (GC/MS) determinations and immunoas-
say results was also reported in a study on dioxin com-
pounds in human milk [30].
Immunoassays are intended to complement and not re-
place conventional analytical techniques. The drawbacks
of chemical instrumental analysis – expensive instrumen-
tation, need for relatively large sample volumes (a partic-
ular drawback in TIE procedures), need for extensive
technical expertise in operation, high costs, relatively
slow sample throughput – are overcome by immunoassay
methods which are technically simple, cost-effective, and
allow rapid throughput of high sample numbers. A further
advantage of immunoassays is their potential on-site ap-
plicability [11, 14]. With these features, immunoassays
can help to identify hot spots, they provide rapid on-site
data (what can be crucial in the case of spills), and they
essentially facilitate bioassay-directed toxicity identifica-
tion procedures. It should be considered, however, that
production and purification of antibodies with high affin-
ity and specificity is often time consuming. The disadvan-
tages of immunoassays include the possible cross-reactiv-
ity of the antibodies to non-target metabolites and matrix
elements of environmental samples leading to an overesti-
mation of contaminant levels, and a comparatively low
sensitivity [9, 23]. This low sensitivity of immunoassays
implies that they cannot reliably identify those samples
that are free of the contaminant.
The immunoassays as described above are just analyt-
ical methods, which are focused on a given, pre-selected
analyte, and differ to chemical analytics mainly in that a
biological molecule instead of a physical principle is used
for determination of the analyte. The bioanalytical meth-
ods discussed in the following sections detect chemicals
on the basis of their ability to interact with a specific bio-
logical target molecule or process, that is the analysis is
not directed towards a specific, pre-selected analyte but
towards the interaction of the analytes with a specific bio-
logical target.
Enzyme inhibition assays
Enzyme inhibition assays such as the cholinesterase inhi-
bition assay [31] or the urease inhibition assay [32], rely
on the property of certain chemicals to inhibit the catalytic
activity of enzymes. Usually, these assays are performed
as microassays with (semi)purified enzyme preparations
[32]. An example is provided by the esterase inhibition as-
say developed by Hamers et al. [31]. The toxicity of or-
ganophosphate and carbamate pesticides is based on their
ability to block esterases thus inhibiting the hydrolysis of
the neurotransmitter acetylcholine by acetylcholine es-
terase. The esterase inhibition assay employs esterase en-
zyme prepared from head homogenates of honey bees
(Apis mellifera). The enzyme preparation is incubated
with dilutions of the test material in 96-well microplates,
and the rate of the esterase-catalysed hydrolysis of the
substrate N-methylindoxyl acetate into the green fluores-
cent product N-methylindoxyl is followed in a fluores-
cence plate reader. If a test sample contains organophos-
phates or carbamates, hydrolysis of the substrate N-methylin-
doxyl by the esterase enzyme is competitively inhibited by
the pesticides and measurable enzyme activity is decreased
compared to controls. Data analysis can be performed by
using Michaelis–Menten kinetics for competitive inhibi-
tion. To this end, the esterase-inhibiting potency of the
sample is quantified as the inhibitor constant Ki, which is
calculated using Lineweaver–Burk equation.
Frequently, the effect strength measured in a bioanalyt-
ical method is expressed as relative potency compared to
a reference compound. This approach offers the possibil-
ity to compare the biological potency of the sample, as de-
termined in the bioanalytical assay, with the theoretical
potency of the sample expected on the basis of chemical
analytical determination of individual components. In their
esterase inhibition assay, Hamers et al. [31, 33] used dichlor-
vos as the reference compound, and the esterase inhibiting
strength of the sample is converted into dichlorvos equiv-
alent concentrations (CDEQ, ng dichlorvos equivalents L–1)
by dividing the Ki-value of dichlorvos by the Ki-value of
the sample. To express the esterase-inhibiting potency of
the sample relative to dichlorvos, the comparison is usu-
ally made at the 50% effect level (EC50), and the concen-
tration–response curves of sample and reference substance
ideally should be parallel. Then, the concentrations (Cx)
of organophosphate and carbamate pesticides in the same
sample are determined by means of chemical analytics,
and for each of the chemically analysed pesticides, the
CDEQ is calculated by multiplying the actual concentration
of the analyte in the sample, Cx, by its esterase-inhibiting
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potency – expressed as concentration leading to 50% inhi-
bition, IC50 – in relation to the IC50 of dichlorvos. Assum-
ing that the joint toxicity of the esterase-inhibiting pesti-
cides in the sample can be described by concentration ad-
ditivity, the theoretically expected esterase-inhibiting po-
tency of the whole sample can be estimated by summing
up the equivalent concentrations CDEQ of the individual
pesticides in the sample. If the chemically derived esterase-
inhibiting potency of the sample is significantly less than
the bioanalytically determined value, this would indicate
that the sample contains additional esterase-inhibiting
chemicals that have been missed in the chemical analysis.
If the bioanalytically determined value is comparatively
less than the analytically derived one, this could indicate
an inhibition of the bioanalytical method (e.g. by matrix
effects). This example clearly illustrates how important it
can be to use chemical analytics and biologically based
analytical tools cooperatively.
Receptor-based assays
Chemicals belonging to several different structural classes
have been identified to induce biological responses
through binding and activation of biological receptor pro-
teins (examples in Table 1). Well-known examples of this
mode of action are certain dioxins, PCBs, PAHs, indo-
carbinoles and imidazoles which are ligands of the aryl
hydrocarbon receptor (AhR). Another group of chemicals
which bind to an endogenous receptor are environmental
estrogens. Actually, this structurally diverse group of nat-
ural, synthetic or industrial compounds, is defined in terms
of their potency to act as ligand of the estrogen receptor
(ER). In the case of the ER, the physiological ligand is the
endogenous estrogen, 17β-estradiol (E2), while for the AhR
no endogenous ligands are known.
We would like to emphasize that we use the term “re-
ceptor” not in the very broad sense as it is often found in
the bioanalytical literature (i.e. as any biological structure,
be it an antibody, enzyme, protein, cell, or tissue, that uti-
lizes a biochemical mechanism for analyte recognition),
but we restrict the use of the term “receptor” to those bio-
logical molecules who have the physiological function of
binding endogenous signal molecules within the organism
and to regulate gene expression [10].
The ability of certain environmental contaminants to
bind to a specific biological receptor protein can be uti-
lized for bioanalytical purposes. A bioanalytical tool that
contains the biological receptor molecule as the sensing
element will be able to selectively recognize all those chem-
icals within a complex sample which are ligands of this
receptor. In fact, a variety of assays systems are based on
the analytical principle of contaminant–receptor binding.
This primary event can then be quantified by a range of
different methods, some of which are illustrated below.
The most straightforward approach is the competitive
ligand binding assay, usually performed as a radioreceptor
assay (RRA). In this method, a solution containing both a
cytosolic or nuclear preparation from a receptor-harbour-
ing tissue, and the radiolabelled physiological ligand of
the receptor are incubated with the chemical or environ-
mental mixture in question. If the chemical or a com-
pound in the mixture is able to bind to the receptor, they
will compete with the labelled ligand for the receptor. Af-
ter incubation, the free radiolabelled ligand is separated
from the receptor-bound ligand and is expressed as the
percentage displaced by the competing compound. RRAs
have been used for the identification of estrogenic poten-
cies, be it of of individual chemicals, environmental mix-
tures or tissue extracts [34, 35, 36, 37]. Interspecies ex-
trapolation of RRA data has to be done with caution, since
binding affinities of the receptors may differ between spe-
cies due to possible differences in receptor structure.
An advantage of the RRA is that it can be used with
preparations from any species, and that it can be performed
rapidly for relatively large sample numbers. The assay does
not distinguish between agonists and antagonists, which
may not be a disadvantage in a primary screen. Disadvan-
tages are that the RRA cannot detect any event down-
stream to primary ligand–receptor interaction, and that the
receptor molecule usually has to be freshly prepared from
tissue homogenates which makes the assay laborious and
also introduces some inter-assay variation (methodologi-
cal variability between individual preparations, individ-
ual- or situation-dependent variation among the donor an-
imals or donor tissues, etc) [38]. The use of recombinant
receptors may eliminate or diminish these confounding
factors.
One application for recombinant receptor molecules is
the enzyme–linked receptor assay (ELRA) [39, 40]. The
ELRA is a microwell-based receptor binding assay using
a receptor produced for instance, in a recombinant yeast
expression system. Measurements are carried out in 96-
well microwell plates. In the ELRA for estrogen receptor
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Table 1 Examples of chemicals that belong to different structural classes, inducing biological effects through binding and activation of
receptor proteins
Receptor Ligands (selection)
Natural or synthetic Xenobiotics
Aryl hydrocarbon receptor Aromatic amines, indocarbinoles, PAHs Dioxins, furans, PCBs, PAHs, imidazoles
Estrogen receptor 17β-estradiol, 17α-ethynylestradiol, flavonoids,  Octylphenol, nonylphenol, bisphenol A, 
genistein hydroxy-PCBs, phthalates, o,p-DDT,
Androgen receptor Testosterone, 11-keto-testosterone,  Vinclozolin, flutamide, p,p′-DDE
5-dihydroxytestosterone
binding chemicals developed by Seifert et al. [40], ini-
tially an estradiol–BSA conjugate is adsorbed to the sur-
face of the microwells. In the second competition step,
an estradiol solution of defined concentration is added
together with the human estrogen receptor alpha. After
the receptor binding reaction, a biotinylated mouse anti-
estrogen receptor antibody is added. When the lumines-
cent substrate luminol is used as label, a detection limit of
0.02 µg E2 L–1 could be achieved [40]. The ELRA approach
has proven to be robust and highly suited for the detection
of natural and synthetic estrogens and xenoestrogens in
field studies.
Another example in which recombinant receptor mole-
cules can be applied in the context of a bioanalytical ap-
plication is affinity chromatography. In this approach, the
receptor molecules are not used for analytical detection –
this is still done by conventional chemical analytical meth-
ods – but the biomolecule is used to enrich the analyte from
complex environmental samples. Receptor molecules are
immobilized on a separation affinity matrix which is then
loaded with the test sample [41]. Subsequent to the “bio-
logical extraction”, the bound substances are eluted from
the column and are subjected to chemical analytics for
substance identification.
A promising approach in which active receptor mole-
cules are directly used in a chemical analytical instrument
is the analytical detection of specific, non-covalent inter-
actions of ligands with for example nuclear receptors us-
ing electrospray ionisation and mass spectrometry [42].
The non-covalent complexes can be studied in the gas or
liquid phase; the latter is generally considered to reflect
the biological system better.
Gene induction assays
These assays measure the induction and reduction of gene
transcription following toxicant exposure. Frequently, the
initial step in the gene induction cascade is binding of the
foreign molecule to a receptor protein, either membrane
bound or intracellular, possibly triggering subsequent sig-
nalling steps, and finally leading to a regulated target gene
expression. In environmental toxicology, the best-studied
examples of chemical binding to endogenous receptors and
subsequent gene induction are chemicals that activate AhR-
regulated and ER-regulated genes (Fig. 1). Binding of ei-
ther a physiological or xenobiotic ligand to AhR or ER re-
sults in a conformational change of the receptor that facil-
itates binding of the activated receptor to specific DNA
sequences (estrogen or dioxin response elements), which
in turn results in a modulation of gene transcription. The
unbound cytoplasmic receptor is maintained in an inactive
conformation through interactions with several associated
proteins, such as the chaperone protein HSP (heat shock
protein) 70. The binding of the endogenous ligand to 
the receptor leads to a dissociation of those associated
proteins and a conformational change of the receptor pro-
tein into the active form. Once activated, the receptors
then form either homodimers or heterodimers, may bind
additional proteins such as ARNT (arylhydrocarbon re-
ceptor nuclear translocator), and are translocated into the
nucleus. There the activated receptor complex binds to spe-
cific DNA motifs, the so-called response element, which
contain the promoter regions for specific genes. Subse-
quently, the transcription of those genes is initiated. The
gene activation can be additionally modulated by tran-
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Fig. 1 Principles of nuclear re-
ceptor-mediated gene activa-
tion
scriptional co-activators which interact with the recep-
tor–DNA complex.
In cell-based assays, either endogenous responses or
exogenous reporter systems incorporated into the cell are
used to quantify the induction of gene transcription, fol-
lowing exposure of the cell to specific ligands or to mix-
tures of compounds. The endogenous products of the in-
duced gene in a genetically non-modified (“wildtype”)
cell can be detected by a variety of techniques, for in-
stance, the mRNA by means of Northern blots or quanti-
tative RT-PCR, the protein by using antibodies in Western
blots or ELISA, and protein activity by means of enzy-
matic assays (Fig. 2). In genetically modified cells, reporter
systems are used to assess gene expression [43]. In the re-
porter assay, the transcription of the endogenous target
gene is induced as well as the gene encoding an easier to
measure and quantifiable “reporter” enzyme (Fig. 2). The
endogenous machinery of the cell translates this product
into a fluorescent protein (e.g. GFP, RFP, BFP, YFP–
green/red/blue/yellow fluorescent protein), or into en-
zymes, such as luciferase, chloramphenicol acetyltrans-
ferase, β-galactosidase or alkaline phosphatase. When sub-
strate is added to the cell culture medium, the enzyme catal-
yses the light-emitting or colorimetric reaction, which is
related to the level of gene induction. The responsiveness
of assays can be characterized by maximal fold induction
relative to control, slope of the dose–response curve, and
detection limit. Genetically engineered cells are reported
to exhibit greater sensitivity, dynamic range and selectiv-
ity than their corresponding wildtype cells [44, 45].
Gene expression assays have the advantage over recep-
tor binding assays in that they can distinguish between ag-
onists and antagonists. Furthermore, post-translational ef-
fects can be observed [38]. Additionally, gene expression
assays have some level of integration in that not only re-
ceptor binding is analysed, but also the consequence of re-
ceptor binding for subsequent gene activation. Depending
on the cell system used, disadvantages of the gene induc-
tion assays may be that they require specialized equip-
ment and trained staff. This is particularly true when using
vertebrate cell lines. Much less difficulties, both in han-
dling, reproducibility and costs, are encountered when yeast-
based or bacteria-based assay systems are being used. If
cell-based gene induction assays are used, care has to be
taken that only non-cytotoxic concentrations of the test
agent are applied. A number of reporter assays are based
on yeast cells. Their cell walls are difficult to be passed
for a range of xenobiotics, what could lead to reduced in-
tracellular accumulation and, consequently, to an underes-
timation of effective concentrations of the test compounds
or samples. Another aspect that has to be considered is the
metabolic activity of the cell system, since for a number
of toxicants it is not the parent compound but the metabo-
lite which binds to the receptors. For instance, Petit et al.
compared the estrogenic effect of 30 chemicals, using a
recombinant reporter yeast assay and primary hepatocytes
of fish, and found that the response of the two bioanalyti-
cal systems differed for more than 30% of the test sub-
stances, probably due to the various metabolic capabilities
of the two assay systems [46].
A variety of gene induction assays based mainly on bac-
terial, yeast, fish and mammalian cells and have been de-
veloped since the early 1990s and applied for the testing
of a broad range of chemicals and environmental and bio-
logical matrices (for recent overviews see refs. [47, 48,
49]). For instance, to measure the dioxin-like activity, re-
combinant yeast cells, continuous teleostean and rodent
cell lines and primary cell cultures from fish, birds and
mammals have been used [50, 51, 52, 53, 54, 55, 56]. Dif-
ferences of the gene induction response among cell sys-
tems derived from various species have been reported [53,
54, 57, 58], which may relate to species-dependent ligand-
binding affinity, in the expression level and structure of
the receptors and their associated proteins, and in the ac-
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tivity of transacting factors [48, 51, 59]. Gene induction
assays have also been frequently applied for the screening
of environmental samples, biological matrices or biologi-
cal mimics such as semipermeable membrane devices [36,
60, 61, 62, 63] and they have been applied in bioassay-di-
rected fractionation procedures [64, 65]. To estimate the
relative potency of chemical mixtures, a toxicity equiva-
lency approach, as described above for the esterase inhi-
bition assay, can be used [48, 58, 66]. Generally, reported
correlations between chemical analyses and gene induc-
tion assays range from reasonable to good. For instance,
in a recent study on dioxin-like contaminants in food sam-
ples, Spearman rank correlation coefficients between 0.67
and 0.73 were observed between chemically determined
dioxin equivalents and equivalents determined by means
of the CALUX reporter gene assay [67]. More importantly,
no false negative results were obtained with the CALUX
assay. Similarly, a correlation coefficient of 0.6 has been
reported between chemically determined estradiol equiva-
lents in wastewater treatment plant effluents and mea-
sured estradiol equivalents using the recombinant yeast
estrogen screen [68]. Also, no negative results were found
here when using the in vitro reporter gene assay. How-
ever, poor correlations between bioanalytical and chemi-
cal analytical data have also been shown. For instance,
Roy et al. [69] examined dioxin equivalents in soil sam-
ples using a CYP1A gene induction assay in the wildtype
H4IIE cell line immunoassay and GC/MS. Correlation co-
efficients were 0.45 between immunoassay and GC/MS,
and 0.08 between the gene induction assay and GC/MS.
One possible explanation for this poor correlation could
be that the assay is inhibited by interfering compounds in
the extract [69]. However, since the gene induction assay
tended to indicate higher dioxin equivalents than GC/MS,
it may also be possible that the GC/MS analysis missed
chemicals with dioxin-like activity present in the sample.
That chemical analysis searching for a number of pre-se-
lected substances may easily overlook biologically active
compounds in an environmental sample is nicely illus-
trated by a recent study by Brack and Schirmer [70].
These authors performed a bioassay-directed fractionation
on a toxic river sediment in order to identify contaminants
with dioxin-like activity. As the bioanalytical tool, they
used a fish cell line measuring AhR-mediated CYP1A in-
duction. As expected, they found high levels of dioxin
equivalents in the more lipophilic fractions, representing
classical dioxin-like chemicals such as PCBs and homo-
cyclic PAHs. Unexpectedly, however, they also noticed
pronounced dioxin-like activity in the more hydrophilic
fractions. These fractions contained heterocyclic O-PAHs
and S-PAHs, which obviously are also CYP1A inducers
but which are not considered in standard chemical analy-
ses. In such a situation, the biological assay would “over-
estimate” the dioxin equivalents in the sediment, if the
comparison to chemically derived dioxin equivalents would
be made only on the basis of analytical determination of
the classical CYP1A inducers.
To determine the biological potency of an environmen-
tal sample, complete concentration–response curves of the
measured gene induction response should be obtained.
However, complex extracts of environmental matrices may
not result in classical, sigmoidal concentration–response
curves, since they can contain cytotoxic substances for in-
stance [48]. Therefore, assays measuring cell viability should
be routinely included when testing environmental sam-
ples. Furthermore, in order to account for obscured con-
centration–response relationships in testing of environ-
mental samples, Brack et al. [65] suggested to use fixed
effect levels in the lower range of the concentration–re-
sponse curve for the determination of dioxin equivalents
in complex samples, for instance, the EC15 level, instead
of using EC50 levels.
Gene induction assays are not necessarily restricted to
the use of in vitro cell systems, but can also be applied
with intact animals in vivo. This was recently demon-
strated by Legler et al. [71]. These authors developed a
novel in vivo testing system on estrogenic substances us-
ing transgenic zebrafish, Danio rerio. In the transgenic ze-
brafish, an estrogen binding sequence linked to a lucif-
erase reporter gene was stably introduced. Binding of a
substance to the endogenous estrogen receptor and the
subsequent activation of the receptor result in luciferase
gene induction that is easily measured in tissue lysates.
This approach offers vast possibilities in rapid screening
for estrogenic exposure, in evaluating tissue-specific ef-
fects of chemical exposure under physiological conditions
and in investigating toxicokinetic parameters.
Bioassay-directed analysis of environmental samples
The concept of bioassay-directed analysis of environmen-
tal samples is based on the toxicity identification evalua-
tion (TIE) approach developed by the US-EPA [72, 73].
The linkage of effect measurements using bioanalytical
tools with chemical analytical procedures has become a
valuable tool for the identification of environmental pol-
lutants as the causative agent for observed effects. Princi-
pally, fractionated environmental samples are analysed on
their effect potential using bioanalytical tools, followed
by a chemical analysis of the active fractions. Further
fractionation, biological effect measurement and chemical
analysis may be repeated until the causative compound
can be identified. Advantage of the bioassay-based analy-
sis is that the analysis is not focussed on the measurement
of a relatively small selection of chemicals, which may be
the wrong (e.g. not the biologically effective) one, but is
based on effects to be studied. A further advantage is that
a lottery-type selection of the possibly relevant chemical
out of the mixture of compounds in an environmental
sample, without having sound selection criteria, is avoided.
The use of this approach has been demonstrated in various
environmental samples such as sediments [74], waste-
water effluents [64, 75], surface waters [76] and others.
Bioanalytical tools used in the bioassay-directed analysis
are various, ranging from sub-cellular to whole organisms.
Whole organisms such as Daphnia and fish are not so
easy to handle and need relatively large sample amounts.
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In addition only descriptive endpoints are measured, such
as death or reduced growth, which do not allow one to
draw any mechanistic conclusion. The use of smaller or-
ganisms has been recognized as being advantageous for
several reasons. They can be maintained under much bet-
ter controlled laboratory conditions. The reproducibility
of the results is increased. They react much faster due to
shorter life cycles and, extremely importantly, require
much smaller sample volumes, thereby saving valuable
samples for subsequent chemical analysis. Indeed, lumi-
nescent bacteria have been used increasingly [75]. Only
very descriptive endpoints are measured in this approach
and hence no hints towards the toxic mechanisms under-
lying the observed effects can be obtained.
We expect major improvement towards the measurement
of specific effects by using bioanalytical tools, which have
been developed on the basis of mechanistic knowledge of
underlying processes. These bioanalytical tools may be an-
tibody-based, receptor-based or gene-induction based as de-
scribed above. A very elegant, illustrative example is de-
scribed by Desbrow et al. [64]. These authors used a genet-
ically modified yeast system to identify estrogenic-active
compounds acting via the estrogen receptor. By using this
bioanalytical tool, the steroid hormones were identified as
the major endocrine-active compounds in communal waste-
water treatment plant effluents. Such mechanism-based,
specific bioanalytical tools, possibly linked with very sensi-
tive molecular detection principles, seem very promising
tools in the bioassay-directed approach.
Despite the fact that the concept of bioassay-directed
analyses of environmental samples is convincing, the sta-
tus of its use is still not very well established. This may be
due to the general fact that the final identification of a spe-
cial causative chemical is very time consuming and there-
fore expensive. A further difficulty is most probably the
absence of sufficient bioanalytical tools, which would al-
low a faster and selective analysis. Bioanalytical tools as
we defined them, linked with molecular detection meth-
ods, will most probably support the further development
of the bioassay-directed analysis.
Conclusions and perspectives
In this manuscript we have discussed the potential of MBBTs
to assess exposure and effect of pollutants, complemen-
tary to chemical analytical methods. MBBTs could over-
come several of the current problems in ecotoxicological
exposure and effects assessment. They allow rapid and cost-
efficient analysis, allow a mechanism-oriented assessment,
supporting the systematization of effects, of interspecies
extrapolation, and the problems of multiple mixture ef-
fects. At the same time, these MBBTs can be valuable as
early warning tools to identify areas or sites at risk, they
can be valuable as guiding tools in exposure assessment
and would lead to the identification and measurement of
the relevant compounds (with respect to the effects) or to
the recognition of the relevant hazards caused by pollu-
tants or mixtures thereof. Thus, MBBTs not only indicate
that certain chemicals are there, but – and this is the ma-
jor advantage of bioanalytical tools – they indicate that
chemicals with a specific mode of toxic action or a spe-
cific toxic potential are there. In this way MBBTs bridge
exposure and effect assessment and help in a faster identi-
fication of the causative agent(s).
Generally, the application of microassays using bacte-
ria, yeast cells, vertebrate cells or invertebrates in environ-
mental assessment has strongly increased in recent years,
particularly because of their advantages in terms of costs,
speed and need for low sample volume [7, 8, 47, 48, 77,
78, 79]. Also, ethical motivations supported the use of mi-
croscaled in vitro assays as alternatives to in vivo animal
toxicity tests [80]. However, it should be emphasized that
many microassays rely on integrative effect endpoints,
such as cytotoxicity, whereas bioanalytical assays – in the
sense as defined in this review – rely on mechanistic mea-
surement principles; in other words, the distinctive crite-
rion of bioanalytical tools is not the microscale nature but
the mechanism-based analytical detection of contaminants.
With MBBTs one cannot only measure if toxic pollu-
tants are present in unknown mixtures but, depending on
the specificity of the assay, also by what mechanism the
effect is caused. In order to be able to fully exploit this po-
tential, knowledge of the toxicological mechanisms is a
prerequisite. Since ecotoxicological research focussed on
mechanistic understanding and application of molecular
approaches is in its childhood, much work needs to be
done [2]. We expect that the need for powerful, sensitive,
specific, fast and cost-efficient bioanalytical tools will in-
crease (e.g. tools that can be used to assess the potential
hazard of pollutants present in environmental samples and
newly synthesized, pure chemicals). The current and in-
tensively debated problem of environmental pollutants
with endocrine-mimicking effects clearly point to that need.
A trend towards the implementation of molecular de-
tection methods in the development of new MBBTs is ob-
vious. Most probably these tools will increase the sensi-
tivity and speed of the measurements. However, without
knowing the biological relevance of the response, they
will stay rather phenomenological, and will not increase
our insight into principles. This insight is urgently needed.
The implementation of modern methods from life sci-
ences, such as functional genomics, in ecotoxicology is
also required. This will speed up the identification of the
key toxicological reactions, the basis for bioanalytical
tool development. Furthermore, the reactions are mea-
sured in a biological context, thereby increasing the rele-
vance of the response measured. Again, much work needs
to be done in this context.
A further promising development for the use of bioan-
alytical tools for exposure and effect assessment is the in-
corporation of nanotechnologically based devices, leading
to the development of portable instruments, the miniatur-
ized measurement of effects, even in arrays of possible ef-
fects or something simple like dipsticks, to be used for the
quick assessment of environmental chemical quality.
The potential for using MBBTs in exposure and effect
assessment seems very promising and rational. With the
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expected increasing need for assessing the potential eco-
toxicological hazards of pollutants and the increasing de-
mand to screen environmental quality and health, these
approaches become increasingly attractive. However, the
application record of the currently available MBBTs is not
so convincing yet. Why is that? Maybe the MBBTs are
not as promising as we think (and say) they are. Their ad-
vantages, in being more specific, mostly more sensitive,
faster, easier to handle, mostly cheaper and less ethically
critical than the currently used tests, dominate. It is there-
fore plausible to assume that the quality of the MBBTs is
good and it will be a matter of time before their use will
increase. Another possibility for the not so frequent use of
the MBBTs might be that the pressure to adopt novel bio-
analytical tools is not high enough yet; the routinely used,
governmentally accepted test systems remain the pre-
ferred ones. Routinely used toxicity test systems and pro-
tocols are known and much experience has been gathered
in using them. Novel MBBTs might be too specific and
too sensitive, causing novel regulatory problems. In addi-
tion the year-long practical experience and immense data
sets are still missing. Finally, in our experience, we have
encountered strong interest in novel MBBTs, up to the
point were legal aspects come into play. As long as the
currently established tests are the ones that form the basis
for legal risk assessment procedures, novel tools will have
a problem in becoming routine.
We are convinced, however, that although much needs
to be done before MBBTs will and can be fully embedded in
toxicological risk assessment and environmental screen-
ing programmes, this approach will become increasingly
used in environmental hazard assessment. When screen-
ing through the current ecotoxicological literature, the
percentage of publications using MBBTs is steadily in-
creasing. Changing threats to our environment bring at-
tention to sub-acute effects occurring below the level of
acute systemic toxicity and demand the development of
assessment tools that are able to detect both the impact of
chronic low-dose exposure to complex chemical mixtures
and the chemicals within these mixtures being responsible
for the effects. Progress in basic research towards the
mechanisms underlying the toxicological processes will
enable the identification of key reactions and target mole-
cules that can be utilized as bioanalytical recognition ele-
ments for rational, targeted environmental assessment.
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